Join a dynamic research team to develop CRISPR–Cas-based electrochemical biosensors that target multidrug resistant Mycobacterium tuberculosis. Work at the forefront of global health innovation as part of a multi-institutional consortium, including ETH Zurich, CSEM, Swiss TPH, and the NCTLD in Georgia. This four-year position offers the chance to work at both ETH Zurich and CSEM, contributing to a project that aims to provide rapid, accurate, and affordable diagnostic solutions for tuberculosis, especially in low- and middle-income countries.

• Develop nucleic acid amplification tests (NAATs) and CRISPR–Cas assays specific for MTB and MDR–MTB
• Create solid-phase electrochemical reporters for CRISPR–Cas assays
• Test developed assays using patient-derived samples
• Perform protein expression
• Collaborate closely with academic and industrial project partners to ensure progress
• Contribute to project management, including financial and time tracking
• Present findings at internal meetings and international conferences
• Write peer-reviewed publications

• Master’s degree in a relevant science or engineering discipline (or equivalent experience)
• Experience in CRISPR–Cas, electrochemical biosensing, biosensing, or analytical chemistry preferred
• Strong motivation and passion for science, engineering, and global health
• Ability to work effectively in a highly international and collaborative environment
• Focus on project objectives and deliverables
• Drive to advance research to higher technology readiness levels
• Strong communication and writing skills

• Multicultural and multidisciplinary research environment
• Attractive hiring conditions
• Access to state-of-the-art equipment and resources
• Strong support for career progression
• Opportunities for travel and fieldwork